Study S000737

Novel Medical Adjunctive Therapy to Catheter Ablation For Atrial Fibrillation (AF)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03856632
Acronym: LEAF
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: ACTIVE_NOT_RECRUITING
Enrollment: 60
Start: 2019-03-18
Primary completion: 2026-12-31
Lead sponsor: University of Miami
Conditions: Atrial Fibrillation
Interventions: DRUG:Liraglutide; OTHER:RFM; DRUG:Anti Arrhythmics; PROCEDURE:Afib Catheter Ablation
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in size of Left Atrial Epicardial Adipose Tissue (LAEAT) [Baseline, 3 months (prior to ablation)]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0003186	The Liraglutide Effects in Atrial Fibrillation (LEAF) Study. Goldberger JJ, JACC. Clinical electrophysiology	2026	Randomized trial	PMID 42159524 DOI	cites ClinicalTrials.gov:NCT03856632; registry reference DERIVED:42159524